2
Views
2
CrossRef citations to date
0
Altmetric
Articles

Flow Cytometry in the Diagnosis of Non-Hodgkin's Lymphoma (NHL)

Pages 219-227 | Published online: 18 Jul 2013
 

Abstract

In recent years, flow cytometry has become an important adjunct to light microscopy in the diagnosis of malignant lymphoma. Flow cytometric techniques are useful in distinguishing benign from malignant lesions and in determining the lineage and stage of differentiation of a neoplastic infiltrate. Certain immunophenotypic antigen profiles are characteristic of specific neoplasms, whereas other profiles are useful as prognostic indicators of outcome. In this review, we present details of the flow cytometric analyses that we perform on suspected lymphoid malignancies, including methods of gating, criteria that we have found useful in distinguishing benign from malignant processes, details of antibody panel selection for two color studies, and common pitfalls in the use of flow cytometry in the clinical laboratory. Highlights of new areas of investigation in the study of malignant lymphomas are presented. By utilizing flow cytometric techniques, these recent scientific advances can be rapidly integrated into routine patient care. As with any specialized diagnostic technique, flow cytometric data must always be integrated with the morphologic and clinical features of each case. (The J Histotechno 1 15:219-227, 1992)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.